Business

The "New Vice" Economy: 5 Stocks Profiting from the Shift to Clean Fuel

VANCOUVER, British Columbia, Dec. 24, 2025 (GLOBE NEWSWIRE) -- USA News Group - News Commentar...

articleCanopy Growth CorporationDecember 24, 20255/company/canopy-growth-corp/news/the-new-vice-economy-5-stocks-profiting-from-the-shift-to-clean-fuel
The "New Vice" Economy: 5 Stocks Profiting from the Shift to Clean Fuel

About this update from Canopy Growth Corporation

[{"type":"text","content":"The \"New Vice\" Economy: 5 Stocks Profiting from the Shift to Clean FuelISSUED ON BEHALF OF DOSEOLOGY SCIENCES INC.\nVANCOUVER, British Columbia, Dec. 24, 2025 (GLOBE NEWSWIRE) -- USA News Group - News Commentary – American consumers are driving record wellness spending as they abandon traditional cigarettes and sugary energy drinks for cleaner, more precise alternatives[1]. The shift is accelerating across functional beverage categories, where protein, adaptogens, and targeted nutrition now dominate new product launches[2]. This consumer-led transformation is positioning several innovative companies to capitalize on the wellness revolution, including Doseology Sciences Inc. (CSE: MOOD) (OTCPK:DOSEF) (FSE: VU70), Philip Morris International (NYSE: PM), Canopy Growth Corporation (NASDAQ: CGC) (TSX: WEED), Zevia PBC (NYSE: ZVIA), and Lifeway Foods (NASDAQ: LWAY). Market analysts tracking healthcare conversations report over 46 million consumer mentions[3] demonstrating unprecedented demand for products delivering measurable health outcomes without compromise. This timing advantage is further amplified by rising health consciousness among younger demographics, who now drive 41% of wellness spending despite representing just 36% of the adult population[4], creating sustained momentum for brands offering functional alternatives to legacy consumption habits. Doseology Sciences Inc. (CSE: MOOD) (OTCPK:DOSEF) (FSE: VU70) is a biotechnology-driven company developing oral delivery platforms for modern stimulants, positioning itself within a consumer shift away from traditional energy drinks, vapes, and cigarettes toward formats designed for precision, control, and convenience. \"Our strategy is clear: to lead innovation in the oral stimulant category with a sharp focus on speed to market and operational excellence,\" said Chris Jackson, CEO of Doseology. In early December 2025, the Kelowna, British Columbia-based company launched a formal Investor Communications Initiative to strengthen disclosure practices and capital markets readiness. The communications push follows a November 2025 announcement in which Doseology secured a strategic manufacturing agreement through Doseology USA Inc., its Florida-based wholly owned subsidiary established in March 2025. The move came after extensive due diligence across North American manufacturi...

More updates from Canopy Growth Corporation